No. of patients | PFS | ||
---|---|---|---|
Multivariate analysis | |||
HR (95% CI) | P | ||
Age, years (continuous) | 168 | 1.025 (0.956–1.099) | 0.4894 |
LC | |||
2006~2012 | 77 | 1 (Reference) | |
2013~2018 | 91 | 0.065 (0.007–0.603) | 0.0162* |
BMI | |||
< 25 | 130 | 1 (Reference) | |
≥ 25 | 38 | 0.243 (0.025–2.404) | 0.2264 |
Stage | |||
IB1, IB2 | 141 | 1 (Reference) | |
IA1, IA2 | 27 | 0.638 (0.092–4.446) | 0.6502 |
Histology | |||
SCC | 118 | 1 (Reference) | |
AC & AS | 50 | 1.367 (0.375–4.986) | 0.6357 |
Invasiveness | |||
< 0.3 cm | 97 | 1 (Reference) | |
≥ 0.3 cm | 71 | 1.139 (0.297–4.363) | 0.8493 |
LVSI | |||
No | 128 | 1 (Reference) | |
Yes | 40 | 4.590 (0.973–21.659) | 0.0543 |
No. of harvested LNs | |||
< 20 | 129 | 1 (Reference) | |
≥ 20 | 39 | 0.325 (0.068–1.557) | 0.1597 |
Metastatic LNs | |||
No | 155 | 1 (Reference) | |
Yes | 13 | 2.609 (0.424–16.041) | 0.3006 |
Tumor size | |||
< 2 cm | 125 | 1 (Reference) | |
≥ 2 cm | 43 | 5.651 (1.255–25.448) | 0.0241* |
Postoperative treatment | |||
Yes | 34 | 1 (Reference) | 0.0755 |
No | 134 | 0.185 (0.029–1.189) |